PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-87356 Oracle Corporation CVE debrief

A high-severity vulnerability exists in Oracle E-Business Suite's Applications Platform Engineering product, specifically in the Valid Session component. This vulnerability, tracked as CVE-2026-87356, allows a low-privileged attacker with logon access to the infrastructure where Applications Platform Engineering executes to easily exploit the vulnerability and compromise the product. Successful exploitation can lead to a takeover of Applications Platform Engineering. The CVSS 3.1 Base Score for this vulnerability is 7.8, indicating a high severity level with impacts on Confidentiality, Integrity, and Availability.

Vendor
Oracle Corporation
Product
Applications Platform Engineering
CVSS
HIGH 7.8
CISA KEV
Not listed in stored evidence
Original CVE published
2026-10-20
Original CVE updated
2026-10-28
Advisory published
2026-10-20
Advisory updated
2026-10-28

Who should care

Defenders responsible for Oracle E-Business Suite Applications Platform Engineering, particularly those managing versions 12.2.3-12.2.15, should assess exposure and prioritize remediation.

Why it matters

CVE-2026-87356 is a high-severity vulnerability in Oracle E-Business Suite's Applications Platform Engineering product. Defenders should prioritize verifying exposure, assessing compensating controls, and applying Oracle's security patches to prevent potential takeover and impacts on Confidentiality, Integrity, and Availability.

  • Potential takeover of Applications Platform Engineering
  • Compromise of Confidentiality, Integrity, and Availability
  • Verification of exposure and compensating controls is necessary

Technical summary

The vulnerability exists in the Valid Session component of Oracle E-Business Suite's Applications Platform Engineering product, affecting versions 12.2.3-12.2.15. It allows a low-privileged attacker with logon access to easily exploit the vulnerability and compromise Applications Platform Engineering, potentially leading to a takeover. Defenders should prioritize verifying exposure, assessing compensating controls, and applying Oracle's security patches to prevent potential impacts on Confidentiality, Integrity, and Availability.

Defensive priority

Defenders should prioritize verifying exposure of Oracle E-Business Suite Applications Platform Engineering versions 12.2.3-12.2.15 and assessing the effectiveness of current compensating controls.

Recommended defensive actions

  • Verify exposure of Oracle E-Business Suite Applications Platform Engineering versions 12.2.3-12.2.15
  • Assess the effectiveness of current compensating controls
  • Review and apply Oracle's security patches for CVE-2026-87356
  • Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
  • Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
  • Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
  • Check relevant monitoring, detection, and logs for exposed assets that need extra review

Evidence notes

The CVE record and NVD entry provide details on the vulnerability, including its description, CVSS score, and affected versions. Oracle's security alert page also offers information on the vulnerability.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-87356 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-87356

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-87356 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-87356

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.